IMPPAT Phytochemical information: 
Digitoxin

Digitoxin
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
Digitoxin Pancreatic cancer trial-1Digi-Panc-1; A prospective single-arm pilot phase II trial of digitoxin in combination with chemotherapy for patients with inoperable pancreatic cancer - Digi-Panc-1CTIS2024-512128-12-01
Digitoxin to improve outcomes in patients with advanced systolic chronic heart failureA multicenter, randomized, double-blind, placebo-controlled study to demonstrate that digitoxin reduces a composite of overall mortality and hospitalization for worsening heart failure in patients with chronic heart failure and reduced ejection fraction - DIGIT-HFEUCTR2013-005326-38-DE
Phase II Study of Digitoxin to Treat Cystic FibrosisPhase II Study of Digitoxin to Treat Cystic FibrosisNCT00782288
A pilot phase II study of digitoxin for Androgen-Independent Prostate Cancer (AIPC)A pilot phase II study of digitoxin for Androgen-Independent Prostate Cancer (AIPC)EUCTR2006-005493-52-SE